Defense Tech Base Research workbooks

US 11338040 B2 / May 24, 2022

Immunomodulatory compounds

This disclosure provides peptide conjugates that are useful for inhibiting the progression of a hyperproliferative disorder, inhibiting the progression of sepsis, inhibiting the progression of an infectious disease, enhancing a response to a vaccine, or inhibiting the progression of a synucleinopathy.

Publication details

Recorded assignee
Leidos, Inc.
Publication number
US 11338040 B2
Publication type
Utility patent grant
Publication date
May 24, 2022
Filing date
Jun 3, 2021
CPC classes
C07K14/4747, C07K14/70503, A61K47/60, C07K14/70596, C07K7/08, A61K38/10, A61K47/62, C07K2319/00
Inventors
Gutierrez; Gabriel M., Pannucci; James, Kotraiah; Vinayaka, Phares; Timothy W., Browne; Cecille D.

Party names reflect the published document. Current ownership and legal status can change.

View patent publication →

Your defense tech briefing

Security verification will run before you submit.